Jeong Woo Cho

Dr. Cho began his career at SK biopharmaceuticals in 2001, becoming COO/EVP and Head of the Drug Development business. In that role, he was responsible for managing all activities associated with the clinical development programs for key CNS assets. Notably, Dr. Cho managed global project teams in the United States, European Union and Asia, which generated 16 US INDs, two global phase 2b/3 programs in direct development and two global NDAs and phase 3 programs in co-development stages.

In March 2017, Dr. Cho rose to become the CEO of SK biopharmaceuticals. A poised and strategic leader, Dr. Cho’s calm demeanor has been pivotal in creating a culture characterized by achievement and excellence across both SK biopharmaceuticals and SK life science.

Dr. Cho was educated at Texas A&M University, where he received his PhD in biology in 1993.